Skip to main content

Greg A. Dadika focuses his practice on advising clients in the pharmaceutical, medical device and health care industry in connection with strategic mass tort litigation and resolution. Greg most recently served as Senior Vice President and Chief Litigation Counsel for a multi-billion dollar medical device company, where he worked as in-house counsel for more than a decade. During that time, Greg built significant experience managing global litigation portfolios and handling large mass torts, some with tens of thousands of plaintiffs. During his tenure, Greg developed and implemented mass tort resolution strategies involving approximately 50,000 claims with billions of dollars at stake, filed against medical device companies. In addition, Greg simultaneously worked to recover over $100 million in insurance proceeds in legal actions, arbitrations, and pre-lawsuit negotiations with dozens of insurance carriers related to disputed insurance coverage for mass tort litigation.

In addition to his experience strategizing and leading mass tort litigation, Greg has coordinated with internal finance and audit teams to manage the financial and cashflow ramifications of mass tort litigations and to resolve matters in a fiscally responsible way in accordance with Generally Accepted Accounting Principles (GAAP). Greg also advised internal teams on appropriate disclosure of significant and material litigation in corporate Securities and Exchange Commission (SEC) filings.

Greg is also experienced in handling U.S.-based federal investigations with state attorneys general, the Department of Justice (DOJ), the SEC, the Food and Drug Administration (FDA), Congress, and the Office of Inspector General for the U.S. Department of Health and Human Services (OIG). His wide-ranging experience spans matters related to antitrust litigation and securities litigation, commercial business disputes, class actions, insurance disputes, and environmental disputes.

Concentrations

  • Pharmaceutical and Medical Device Litigation
  • Product Liability & Mass Torts
  • Complex Commercial Litigation
  • M&A Due Diligence

取扱分野

実績紹介

  • While serving as in-house counsel for a multi-billion dollar medical device company, Greg resolved approximately 50,000 claims filed against the company with billions of dollars in potential liabilities at stake.°
  • While serving as in-house counsel for a multi-billion dollar medical device company, Greg recovered over $100 million in insurance proceeds through legal actions, arbitrations, and pre-lawsuit negotiations with dozens of insurance carriers related to disputed insurance coverage for mass tort litigation.°

°The above representations were handled by Mr. Dadika prior to joining Greenberg Traurig, LLP.

  • Adjunct Professor of Law, Seton Hall University School of Law, 2003-2008
  • Becton, Dickinson and Company
    • Senior Vice President and Chief Litigation Counsel, 2020-2021
    • Deputy Chief Litigation Counsel, 2019-2020
    • Associate General Counsel, Litigation, 2017-2019
  • C. R. Bard, Inc.
    • Associate General Counsel, Litigation, 2013-2017
    • Assistant General Counsel, Litigation, 2008-2013

受賞歴・所属団体

  • BD Law Department Impact Award, 2019 – Awarded to Becton, Dickinson Law Department employee who made the most significant impact upon the business of the company.
  • Member, Higgins Classic Committee Special Olympics of New Jersey, 2009-Present
    • Chair, Higgins Classic Committee Special Olympics of New Jersey, 2016-Present

学歴・資格・言語

学歴
  • 法務博士, cum laude, Seton Hall University School of Law, 1999
  • 学士号, with honors, Rutgers University, 1996
Clerkships
  • Hon. Virginia A. Long, New Jersey Supreme Court, 1999-2000
弁護士資格
  • New Jersey
  • 米国 ニューヨーク州